Inicio › Enfermedad de Crohn › Pensilvania
Ensayos clínicos de Enfermedad de Crohn en Pensilvania
21 estudios sobre Enfermedad de Crohn buscan participantes en Pensilvania.
Ciudades en Pensilvania
Texto oficial del estudio (inglés)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT03816345A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Penn State University Milton S. Hershey Medical Center ( Site 5102), Hershey
- Thomas Jefferson University Hospital ( Site 5133), Philadelphia
- Frontier Clinical Research, LLC ( Site 5098), Uniontown
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 10 nov 2026 · NCT06430801Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 4 nov 2026 · NCT06937099A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, Harrisburg
- Penn State Milton S Hershey Medical Ctr, Hershey
- University of Pennsylvania, Philadelphia
- y 1 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07196722A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Michigan Center of Medical Research, Farmington Hill
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07577843A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 3 nov 2026 · NCT05923073A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Frontier Clinical Research, Uniontown
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT07499232A Study to Investigate Efficacy and Safety of Brivekimig in Participants With Crohn's Disease
- Investigational Site Number: 8400009, Harrisburg
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 nov 2026 · NCT06958536A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07184944An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Penn State Milton S. Hershey Medical Center-Site Number: 8400066, Hershey
- University of Pennsylvania School of Medicine-Site Number: 8400072, Philadelphia
- The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107, Pittsburgh
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 21 oct 2026 · NCT07184931A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Penn State Health Milton South Hershey Medical Center, Hershey
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 9 oct 2026 · NCT06405087A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Children's Hospital of Philadelphia (CHOP), Philadelphia
ReclutandoFase 3
Edades de 2 a 19 · Todos los sexos · Actualizado el 7 oct 2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Children's Hospital of Philadelphia, Philadelphia
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 7 oct 2026 · NCT05509777Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- University of Pennsylvania - Perelman Center for Advanced Medicine /ID# 265904, Philadelphia
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
- Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 5 may 2026 · NCT04779320Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Susquehanna Research Group, LLC, Harrisburg
- UPMC, Pittsburgh
- Frontier Clinical Research, LLC, Uniontown
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 abr 2026 · NCT06456593COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
- University of Pittsburgh Medical Center, Children's Hospital, Pittsburgh
ReclutandoEstudio observacional
Edades de 1 a 18 · Todos los sexos · Actualizado el 17 abr 2026 · NCT07198113Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoEstudio observacional
2 Months – 60 Years · Todos los sexos · Actualizado el 13 ene 2026 · NCT04528355Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
ReclutandoFase 2
2 Months – 55 Years · Todos los sexos · Actualizado el 15 dic 2025 · NCT01962415Autologous Stem Cell Transplantation for Crohn's Disease
- UPMC Prebyterian- Adult Gastroenterology, Pittsburgh
- Children's Hospital of Pittsburgh of UPMC-Bone Marrow Team, Pittsburgh
ReclutandoFase 1/2
Edades de 10 a 60 · Todos los sexos · Actualizado el 15 dic 2025 · NCT00692939Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Children's Hospital of Philadelphia, Philadelphia
Reclutando
Edades de 8 a 21 · Todos los sexos · Actualizado el 12 jun 2025 · NCT06216899De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.